At Atley's Radiochemistry department, we develop novel and cutting edge At-211 radiochemistry, ensure Atley products can perform robust radiochemical processes, and help our customers develop and automate At-211 labelling.
About Atley Solutions
Atley Solutions develops technology and know-how related to the development and production of radiopharmaceuticals based on the alpha emitting radionuclide astatine-211. These radiopharmaceuticals are used in Targeted Alpha Therapy, a promising treatment for disseminated cancer.
Targeted Alpha Therapy has the potential to improve and save millions of lives. For this to happen, Atley is needed.
Already working at Atley Solutions?
Let’s recruit together and find your next colleague.